|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-9-12
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
The aim of this study was to select the best catumaxomab regimen for further investigation in ovarian cancer based on confirmed tumour response.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1095-6859
|
|
pubmed:author |
pubmed-author:BaumannKK,
pubmed-author:BurchardiNN,
pubmed-author:HuoberJJ,
pubmed-author:KurzederCC,
pubmed-author:LückH JHJ,
pubmed-author:LoiblSS,
pubmed-author:PfistererJJ,
pubmed-author:SchmalfeldtBB,
pubmed-author:SehouliJJ,
pubmed-author:VergoteII,
pubmed-author:WagnerUU,
pubmed-author:WimbergerPP,
pubmed-author:du BoisAA
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
123
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
27-32
|
|
pubmed:meshHeading |
pubmed-meshheading:21733566-Adult,
pubmed-meshheading:21733566-Aged,
pubmed-meshheading:21733566-Aged, 80 and over,
pubmed-meshheading:21733566-Antibodies, Bispecific,
pubmed-meshheading:21733566-Disease-Free Survival,
pubmed-meshheading:21733566-Dose-Response Relationship, Drug,
pubmed-meshheading:21733566-Drug Resistance, Neoplasm,
pubmed-meshheading:21733566-Female,
pubmed-meshheading:21733566-Humans,
pubmed-meshheading:21733566-Infusions, Parenteral,
pubmed-meshheading:21733566-Middle Aged,
pubmed-meshheading:21733566-Neoplasms, Glandular and Epithelial,
pubmed-meshheading:21733566-Organoplatinum Compounds,
pubmed-meshheading:21733566-Ovarian Neoplasms
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: a phase IIa study of the AGO Study Group.
|
|
pubmed:affiliation |
University of Marburg, Department of Gynaecology, Marburg, Germany. baumannk@med.uni-marburg.de
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase II
|
